On #RareDiseaseDay, we honor the millions worldwide navigating life with rare diseases. Our research aims to evaluate the value, cost-effectiveness and implementation of genomic technologies in the health system to improve the health of rare disease patients and their families.

Terrific to see our study highlighted Genetics in Medicine 👏 Ilias Goranitis Dylan Mordaunt Victorian Clinical Genetics Services (VCGS) @EiGen_UoM Australian Genomics certainly hope it helps to inform reimbursement decisions! 🧬💰

Meet the team: Daniel is a PhD candidate Economics of Genomics and Precision Medicine Unit. His research focuses on valuing preferences in genomic testing. He is currently focused on the health economics of additional findings in Australia. In his spare time, Daniel enjoys cooking, hiking, & board games.

A new study by our team, in collaboration with Australian Genomics, highlights priority indicators for assessing the value of genomic testing in rare diseases, a much-needed effort to standardise evidence generation. Read more here: pubmed.ncbi.nlm.nih.gov/38459833/ #Genomics #RareDiseases

Francisco is a PhD candidate at @EiGEN_UOM. His work explores the value, cost effectiveness, and policy implications of providing functional genomic diagnostics for rare disease. In his spare time, you'll find Francisco discovering a new sport 🥊 or finding the best ☕️ on campus.

Excited to announce our newest team member: Xiuqin Xiong! 👏Xiuqin has recently completed her PhD and will be joining us to research the cost-effectiveness of biomarkers in detecting neurological disorders, as well as preferences for research participation among CALD populations.

Congratulations to Ilias and Riccarda on their recent publication! The BabyScreen+ study explores a newborn screening program incorporating genomic sequencing to detect a wider range of childhood-onset conditions. #GenomicNewbornScreening bmjopen.bmj.com/content/14/4/e…

Meet the team: Florencia is a research assistant in Economics of Genomics and Precision Medicine Unit. Her research focuses on early health technology assessment for genomic medicine in transplant care and models of care for genomics services. Florencia loves listening to 🎶 and exploring Melbourne’s top food spots.

Come and join the EiGEN team! 🎓We have two new exciting PhD opportunities available exploring health economics and Indigenous genomics. For more information on the projects and details on how to apply, follow the links below: tiny.cc/PhDOpportunity1 tiny.cc/PhDOpportunity2

This week, two of our PhD students, Francisco and Dylan, were invited to present at the Peter Mac Cancer Centre Health Services Research and Implementation Science Seminar Series. They presented on the topic of micro-costing methodologies and how they can be applied to genomics research 🧬

A great new commentary piece by the GEECS on the global implementation of genomic sequencing. Read more here: academic.oup.com/healthaffairss…

Congratulations to our Economics of Genomics and Precision Medicine Unit team members Ilias and Riccarda on their latest publication 🙌 This paper explores public preferences and perspectives on which conditions to include in genomic newborn screening (gNBS). Read more here: link.springer.com/article/10.118…

Meet the team: Louise is a project officer at Economics of Genomics and Precision Medicine Unit, responsible for the coordination and management of the unit’s numerous projects. She is currently working on a DCE to understand preferences for genomic data governance. Louise loves Pilates, sweet treats, and dog beaches.

Meet the team: Mac is a PhD student and research assistant at Economics of Genomics and Precision Medicine Unit. His research focuses on the methodology of economic evaluation of population screening for cancer. In his spare time, Mac enjoys running, surfing, and reading🏄.

🎓Are you passionate about #IndigenousHealth, #genomics and #HealthEconomics? We have two PhD opportunities available in collaboration with Australian Genomics and the Australian Alliance for Indigenous Genomics (#ALIGN). tiny.cc/PhDOpportunity1 tiny.cc/PhDOpportunity2

A fantastic webinar is being held early tomorrow morning by IHEA Economics of Genomics & Precision Medicine. Join Professor David Veenstra as he explores the important question: Should genomic screening be conducted for all adults? Register here: lnkd.in/gkvP5PGF #IHEA #healtheconomics #genomics

Congratulations to our team member, Francisco, for presenting his research on the health economics of functional genomic (FG) testing for rare diseases at the EuHEA Conference in Vienna!

For those who missed it, Professor David Veenstra's insightful talk, "Should Genomic Screening Be Conducted for All Adults?", is now available online. Watch it here: youtube.com/watch?v=c62ddO…

🚨Exciting news!🚨 Mac, Riccarda Dr Riccarda Peters and Lizzy Lizzy Liu , alongside Prof. Zanfina Ademi Zanfina Ademi from Monash University will be presenting at the upcoming #AHES2024 as part of the organized session "Novel Application of Health Economic Methods in Genomic Medicine".

Join us for presentations and discussions on integrating #HealthEconomics with #Genomics. Let’s explore innovative approaches with the potential to influence national health policies! 📅 Time: 9.00-10.20, 20 Sept 2024 📍 Venue: Thomas Keneally Room, Sydney Harbour Marriott Hotel